Latest Europe News

EcoGraf has strengthened the technical and commercial case for its Tanzanian graphite strategy, including a larger Epanko ore reserve and planned downstream processing. But cash fell to A$3.8 million, and auditors flagged a material uncertainty over the company’s ability to continue as a going concern.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.

Vection Technologies has signed reciprocal five-year reseller agreements with Xerox, opening a potential Western European channel for its conversational AI, digital human, kiosk and XR technologies. The opportunity is strategically notable, but the agreements contain no minimum volumes, pricing or committed revenue.

Elementos has materially strengthened its balance sheet while moving its Spanish Oropesa tin project closer to permitting, financing and a final investment decision. The annual report also highlights a doubling of Cleveland’s inferred tungsten resource, but both projects still require substantial capital and further approvals.

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

Globe International increased FY2026 EBIT and net profit despite almost no revenue growth, as a tighter brand portfolio improved margins across all three regions. The ASX-listed group also lifted its fully franked annual dividend to 23 cents per share and ended the year with A$26.7 million in cash.

Memphasys has signed a three-year exclusive distribution agreement covering the Czech Republic, Slovakia and Kazakhstan, with minimum purchases worth approximately A$674,000. The deal expands Felix’s European footprint while adding dedicated commercial leadership in the region.

Patrys has formed an international Clinical Advisory Committee to help shape the next stages of RLS-2202, its injectable quetiapine candidate for delirium in acute-care settings. The appointments add recognised expertise in delirium research, intensive care and trial design, but do not yet provide clinical efficacy or regulatory evidence.

Dyno Nobel has reaffirmed its FY26 outlook and retained its A$600 million FY28 underlying EBIT ambition, while setting a new A$800 million target for FY31. The explosives maker is positioning defence energetics, premium technology and growth in mining markets as the next leg of expansion.

Talga has signed a non-binding LOI with German battery maker EAS Batteries for a potential five-year supply agreement covering Talnode graphite anode products. No volumes or purchase obligations have been agreed, with product qualification and negotiations now scheduled to run into 2027.

Li-S Energy says its Geelong lithium-sulfur production line is complete and has delivered 10Ah Power Cells to the US Army for testing. The company is targeting its first commercial battery sale in 2027, while holding A$15.6 million in cash and investments and A$9.3 million in secured grants yet to be received.

Cazaly Resources will replace managing director Tara French with mining executive Adrian Byass from 8 October, while launching a review of its exploration portfolio. Byass will receive a $325,000 annual salary and may be granted up to 7 million performance rights, subject to approval and conditions.